-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $435

Benzinga·07/15/2026 15:46:17
语音播报
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $534 to $435.